Search

everythinglearnresearchcommunity

for

Search:↓

Taking alfuzosin and finasteride together caused temporary vision loss in a glaucoma patient, but switching to tamsulosin helped.

Hormonal therapy for transgender individuals carries health risks but is a personal choice.

Finasteride may cause kidney damage.

The doxazosin plus tamsulosin combination improved symptoms effectively with fewer side effects.

Hormones significantly affect women's sexual function, and more research is needed to improve treatments for sexual dysfunction with minimal side effects.

Skin problems are common in kidney disease, with dry skin and itching in patients not on dialysis or on hemodialysis, and infections most common in transplant recipients.

Pre-operative hormone treatment for hypospadias surgery might improve outcomes, but more research is needed to confirm.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Finasteride and DEHP exposure during development can change reproductive markers in rats.

Finasteride treatment for three years changes certain polyamine levels in the blood but not in urine.

Pregnancy causes temporary skin changes that are usually harmless.

Women with pancreatic cancer are more likely to have certain side effects from chemotherapy than men.

Finasteride reduces PSA levels by around 40-50% in BPH patients.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

Most hypothyroid patients experience dry skin and swelling.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Androgens, like testosterone, are crucial for early testicular descent in rats.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Prostate cancer patients need early psychological and sexual support during radiotherapy to improve their quality of life.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.

The 2024 guideline updates recommendations for genetic testing, imaging, and sperm retrieval in male infertility.

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

Skin changes during pregnancy are common, and non-invasive imaging is safe for monitoring these changes.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Finasteride significantly reduced sperm production and caused testicular atrophy in hamsters.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Potential androgen excess signs vary by demographics and health, needing inclusive evaluation.

Combining modern and Unani medicine may improve BPH treatment with fewer side effects.